Abrdn PLC Biomarin Pharmaceutical Inc Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Abrdn PLC holds 527,681 shares of BMRN stock, worth $35.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

527,681

Previous 494,441 6.72%

Holding current value

$35.2 Million

Previous $40.7 Million 8.89%

% of portfolio

0.07%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$69.02 - $93.84 $2.29 Million - $3.12 Million	33,240 Added 6.72%	527,681 $37.1 Million
Q2 2024 Aug 09, 2024	BUY	$74.43 - $92.22 $6.08 Million - $7.53 Million	81,626 Added 19.77%	494,441 $40.7 Million
Q1 2024 May 08, 2024	BUY	$83.81 - $99.0 $3.07 Million - $3.62 Million	36,577 Added 9.72%	412,815 $36.1 Million
Q4 2023 Jan 31, 2024	BUY	$76.22 - $98.51 $26.2 Million - $33.8 Million	343,615 Added 1053.29%	376,238 $36.3 Million
Q3 2023 Nov 06, 2023	SELL	$85.07 - $94.48 $9,272 - $10,298	-109 Reduced 0.33%	32,623 $2.89 Million
Q2 2023 Jun 20, 2024	SELL	$86.68 - $100.3 $24,617 - $28,485	-284 Reduced 0.86%	32,732 $2.84 Million
Q2 2023 Aug 04, 2023	SELL	$86.68 - $100.3 $24,617 - $28,485	-284 Reduced 0.86%	32,732 $2.84 Million
Q1 2023 Jun 20, 2024	BUY	$87.74 - $117.27 $1.35 Million - $1.8 Million	15,387 Added 87.28%	33,016 $3.21 Million
Q1 2023 Apr 28, 2023	BUY	$87.74 - $117.27 $1.35 Million - $1.8 Million	15,387 Added 87.28%	33,016 $3.21 Million
Q4 2022 Jun 20, 2024	SELL	$80.93 - $108.63 $32 Million - $42.9 Million	-395,186 Reduced 95.73%	17,629 $1.82 Million
Q4 2022 Feb 09, 2023	BUY	$80.93 - $108.63 $90,803 - $121,882	1,122 Added 6.8%	17,629 $1.82 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $701,646 - $827,867	-8,540 Reduced 34.1%	16,507 $1.4 Million
Q2 2022 Aug 05, 2022	BUY	$71.48 - $86.85 $142,173 - $172,744	1,989 Added 8.63%	25,047 $2.08 Million
Q1 2022 May 04, 2022	BUY	$74.28 - $92.69 $211,623 - $264,073	2,849 Added 14.1%	23,058 $1.79 Million
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $61,033 - $77,840	851 Added 4.4%	20,209 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $256,535 - $293,247	3,431 Added 21.54%	19,358 $1.5 Million
Q2 2021 Aug 10, 2021	SELL	$75.51 - $84.79 $239,744 - $269,208	-3,175 Reduced 16.62%	15,927 $1.33 Million
Q1 2021 May 06, 2021	BUY	$74.73 - $90.69 $30,265 - $36,729	405 Added 2.17%	19,102 $1.44 Million
Q4 2020 Feb 10, 2021	BUY	$72.61 - $90.2 $28,317 - $35,178	390 Added 2.13%	18,697 $1.64 Million
Q3 2020 Oct 21, 2020	SELL	$71.87 - $131.03 $367,399 - $669,825	-5,112 Reduced 21.83%	18,307 $1.39 Million
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $28,797 - $44,967	-362 Reduced 1.52%	23,419 $2.89 Million
Q1 2020 May 13, 2020	SELL	$71.37 - $96.85 $18,342 - $24,890	-257 Reduced 1.07%	23,781 $2.01 Million
Q4 2019 Feb 18, 2020	BUY	$64.27 - $86.37 $17,417 - $23,406	271 Added 1.14%	24,038 $2.03 Million
Q3 2019 Nov 13, 2019	BUY	$67.4 - $85.11 $60,120 - $75,918	892 Added 3.9%	23,767 $1.6 Million
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $7,472 - $8,732	93 Added 0.41%	22,875 $1.96 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $1.13 Million - $1.32 Million	13,433 Added 143.68%	22,782 $2.02 Million
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $7,853 - $10,394	-98 Reduced 1.04%	9,349 $785,000
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $33,341 - $37,530	-355 Reduced 3.62%	9,447 $916,000
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $745,050 - $970,692	9,802 New	9,802 $923,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account